Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Other Accumulated Expenses: 2018-2024

Historic Other Accumulated Expenses for Bicycle Therapeutics (BCYC) over the last 7 years, with Dec 2024 value amounting to $297,000.

  • Bicycle Therapeutics' Other Accumulated Expenses fell 48.87% to $204,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $204,000, marking a year-over-year decrease of 48.87%. This contributed to the annual value of $297,000 for FY2024, which is 15.56% up from last year.
  • According to the latest figures from FY2024, Bicycle Therapeutics' Other Accumulated Expenses is $297,000, which was up 15.56% from $257,000 recorded in FY2023.
  • Bicycle Therapeutics' 5-year Other Accumulated Expenses high stood at $1.5 million for FY2022, and its period low was $208,000 during FY2020.
  • Over the past 3 years, Bicycle Therapeutics' median Other Accumulated Expenses value was $297,000 (recorded in 2024), while the average stood at $675,333.
  • Per our database at Business Quant, Bicycle Therapeutics' Other Accumulated Expenses spiked by 210.45% in 2020 and then tumbled by 82.54% in 2023.
  • Yearly analysis of 5 years shows Bicycle Therapeutics' Other Accumulated Expenses stood at $208,000 in 2020, then surged by 174.04% to $570,000 in 2021, then skyrocketed by 158.25% to $1.5 million in 2022, then plummeted by 82.54% to $257,000 in 2023, then grew by 15.56% to $297,000 in 2024.